Lenalidomide safe as single therapy for elderly CLL patients

The oral medication lenalidomide is safe and well-tolerated for elderly patients with chronic lymphocytic leukaemia, a group without a well-defined frontline therapy for their disease, researchers from The University of Texas M. D. Anderson Cancer Centre reported at the 50th annual meeting of the American Society of Hematology...

Read the whole article on

More from